CD8A and melanoma: Recently, Shimizu and colleagues showed that vaccination with B16 melanoma cells loaded with the invariant NKT cell ligand αGalCer stimulated tumor-reactive CD8+ memory T cells in a novel mechanism involving cross-talk between XCR1-expressing DC and pDC via NKT-stimulated IFN-α production by pDC (33).